TrademarkDir
EXONEURAL MEDICINE PLATFORM
DEAD

Serial Number

88651546

Owner

Cygnal Therapeutics, Inc.

Attorney

Christina M. Licursi

First Use Date

Oct 8, 2019

Filing Date

Oct 11, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EXONEURAL MEDICINE PLATFORM Trademark

Serial Number: 88651546

EXONEURAL MEDICINE PLATFORM is a trademark filed by Cygnal Therapeutics, Inc. on October 11, 2019. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Cygnal Therapeutics, Inc. (9 trademarks)

325 Vassar Street, Suite 2B
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

October 11, 2019

Registration Date

Not Registered

First Use Anywhere

October 8, 2019

First Use in Commerce

October 8, 2019

Published for Opposition

February 25, 2020

Goods & Services

Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; Platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jun 6, 2022 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jun 6, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 6, 2022 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 22, 2021 GNFN
FINAL REFUSAL E-MAILED
Nov 22, 2021 GNFR
SU - FINAL REFUSAL - WRITTEN
Nov 22, 2021 CNFR
ASSIGNED TO EXAMINER
Nov 16, 2021 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 13, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 12, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 12, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 1, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jun 1, 2021 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jun 1, 2021 CNRT
STATEMENT OF USE PROCESSING COMPLETE
May 6, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 6, 2021 AITU
USE AMENDMENT FILED
Apr 21, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 21, 2021 EISU
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 26, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 26, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 26, 2021 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 22, 2020 EXRA
SOU EXTENSION 1 GRANTED
Oct 20, 2020 EX1G
SOU EXTENSION 1 FILED
Oct 20, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 20, 2020 EEXT
ASSIGNED TO EXAMINER
Oct 20, 2020 DOCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 21, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 25, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 25, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 5, 2020 NONP
ASSIGNED TO LIE
Jan 21, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 17, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 17, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 17, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 17, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 17, 2020 CNEA
ASSIGNED TO EXAMINER
Jan 16, 2020 DOCK
TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 19, 2019 PARI
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Dec 18, 2019 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 18, 2019 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 17, 2019 NWOS

Related Trademarks

More from this Owner

PIONEERING EXONEURAL BIOLOGY

PIONEERING EXONEURAL BIOLOGY

PIONEERING EXONEURAL MEDICINES

PIONEERING EXONEURAL MEDICINES

PIONEERING EXONEURAL BIOLOGY

PIONEERING EXONEURAL BIOLOGY

PIONEERING EXONEURAL MEDICINES

PIONEERING EXONEURAL MEDICINES

EXONEUROGENESIS

EXONEUROGENESIS

EXONEUROGENESIS

EXONEUROGENESIS